Companies Dominating the Qualitative Platelet Disorders Treatment Landscape
- Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- Siemens Healthcare GmbH
- Boehringer Ingelheim International GmbH
- Johnson & Johnson Services, Inc.
- Baxter International, Inc.
- Novartis AG
- Abbott Laboratories
- Sanofi-aventis Groupe
- AbbVie Inc.
Browse Key Market Insights with Data Illustration:
In the News
-
Sanofi-aventis Groupe acquired Provention Bio, Inc., to provide best-in-class medications, and to provide those at risk of developing Stage 3 type 1 diabetes with life-changing advantages. Further, the acquisition also advances the company's strategy to move towards pharmaceuticals with distinctive profiles.
- acquired cardiovascular Systems, Inc. (CSI), to enhance its industry-leading vascular device solutions with new innovations.
